Back to BALYASNY ASSET MANAGEMENT L.P.

CTNM
3 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in CONTINEUM THERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. holds 1.7M shares of CTNM (CONTINEUM THERAPEUTICS INC), worth $22M as of 2026-Q1. The position was decreased (-8.5% shares). CTNM represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$22M

Current Shares

1.7M

Total Value Change

+$10.8M

Total Shares Change

+734,315

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.7M
-8.5%
$22M0.0%$14.10
0
2025-Q4
Increased
1.8M
+93.7%
$21.1M0.0%$11.40
45
2025-Q3
New
951,320
-
$11.2M0.0%$11.82
38

Other major holders of CTNM: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used